A new rapid and effective chemistry space filter in recognizing a druglike database

被引:65
作者
Zheng, SX
Luo, XM
Chen, G
Zhu, WL
Shen, JH
Chen, KX
Jiang, HL
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China
[2] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
关键词
D O I
10.1021/ci050031j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To develop a new chemistry space filter with high efficiency and accuracy, an analysis on distributions of as many as 50 structural and physicochemical properties was carried out on both druglike and nondruglike databases, viz. MACCS-II Drug Data Report (MDDR), Comprehensive Medicinal Chemistry (CMC), and Available Chemicals Directory (ACD). Based on the analysis results, a chemistry space filter was developed that can effectively discriminate a druglike database from a nondruglike database. The filter is composed of two descriptors: one is a molecular saturation related descriptor, and the other is associated with the proportion of heteroatoms in a molecule. Both are molecular size independent. Therefore, the profiles of a druglike database could be characterized as proper molecular saturation and proper percentage of heteroatoms, revealing direct indices for designing and optimizing combinatorial libraries. The application of the new filter on the Chinese Natural Product Database (CNPD) suggested that CNPD is, as expected, a potential druglike database, testifying that the new filter is reliable. Therefore, this newly developed chemistry space filter should be a potent tool for identifying druglike molecules, thus, it would have potential applications in the research of combinatorial library design and virtual hi It throughput screening using computational approaches for drug discovery.
引用
收藏
页码:856 / 862
页数:7
相关论文
共 34 条
[1]   Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? [J].
Ajay ;
Walters, WP ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3314-3324
[2]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[3]   Computational methods for the prediction of 'drug-likeness' [J].
Clark, DE ;
Pickett, SD .
DRUG DISCOVERY TODAY, 2000, 5 (02) :49-58
[4]   Natural products in drug discovery and development [J].
Cragg, GM ;
Newman, DJ ;
Snader, KM .
JOURNAL OF NATURAL PRODUCTS, 1997, 60 (01) :52-60
[5]   Profiling drug-like properties in discovery research [J].
Di, L ;
Kerns, EH .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (03) :402-408
[6]   Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry [J].
Feher, M ;
Schmidt, JM .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (01) :218-227
[7]   Improving the odds in discriminating "Drug-like" from "Non Drug-like" compounds [J].
Frimurer, TM ;
Bywater, R ;
Nærum, L ;
Lauritsen, LN ;
Brunak, S .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (06) :1315-1324
[8]   Identification of biological activity profiles using substructural analysis and genetic algorithms [J].
Gillet, VJ ;
Willett, P ;
Bradshaw, J .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1998, 38 (02) :165-179
[9]   High-throughput and virtual screening: core lead discovery technologies move towards integration [J].
Good, AC ;
Krystek, SR ;
Mason, JS .
DRUG DISCOVERY TODAY, 2000, 5 (12) :S61-S69
[10]  
Henkel T, 1999, ANGEW CHEM INT EDIT, V38, P643, DOI 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO